Max Chat
Company Analysis Shanghai Haohai Biological Technology Co., Ltd.
1. Summary
Advantages
- Price (0 Β₯) is less than fair price (13.05 Β₯)
- Dividends (1.37%) are higher than the sector average (0.3202%).
- The company's current efficiency (ROE=3.56%) is higher than the sector average (ROE=2.65%)
Disadvantages
- The stock's return over the last year (0%) is lower than the sector average (14.83%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Shanghai Haohai Biological Technology Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 4.8% | 0.5% |
| 90 days | 0% | 8.1% | 14.9% |
| 1 year | 0% | 14.8% | 31.4% |
6826 vs Sector: Shanghai Haohai Biological Technology Co., Ltd. has significantly underperformed the "Healthcare" sector by -14.83% over the past year.
6826 vs Market: Shanghai Haohai Biological Technology Co., Ltd. has significantly underperformed the market by -31.36% over the past year.
Stable price: 6826 is not significantly more volatile than the rest of the market on "Shanghai Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 6826 with weekly volatility of 0% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0 Β₯) is lower than the fair price (13.05 Β₯).
4.2. P/E
P/E vs Sector: The company's P/E (28.6) is lower than that of the sector as a whole (118.32).
P/E vs Market: The company's P/E (28.6) is lower than that of the market as a whole (69.6).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.92) is lower than that of the sector as a whole (5.73).
P/BV vs Market: The company's P/BV (0.92) is lower than that of the market as a whole (3.04).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.45) is lower than that of the sector as a whole (16.05).
P/S vs Market: The company's P/S indicator (2.45) is lower than that of the market as a whole (6.18).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (25.97) is higher than that of the sector as a whole (16.62).
EV/Ebitda vs Market: The company's EV/Ebitda (25.97) is higher than that of the market as a whole (17.31).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by 0% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (0%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (8.87%).
5.4. ROE
ROE vs Sector: The company's ROE (3.56%) is higher than that of the sector as a whole (2.65%).
ROE vs Market: The company's ROE (3.56%) is lower than that of the market as a whole (6.13%).
5.5. ROA
ROA vs Sector: The company's ROA (1.93%) is lower than that of the sector as a whole (3.24%).
ROA vs Market: The company's ROA (1.93%) is lower than that of the market as a whole (3.23%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 1.37% is higher than the average for the sector '0.3202%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.37% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 1.37% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (67.87%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
